تحميل
HKSEHealthcareMedical - Care Facilities
أحدث البيانات المتاحة
0.106 HK$
−0.004 HK$ · -3.64%
Raily Aesthetic Medicine International Holdings Limited is an investment holding company primarily engaged in providing a comprehensive range of cosmetic medical services. Its operations are structured into three principal segments: Aesthetic Medical Services, Consulting Services, and the distribution of Aesthetic Medical Equipment Products. The company's service offerings include various aesthetic procedures such as: Surgical interventions: encompassing cosmetic surgeries performed on different areas of the face or body. Minimally invasive treatments: largely consisting of aesthetic injection procedures. Aesthetic dermatology: featuring diverse energy-based treatments. Aesthetic dental care: including orthodontic services, dental implants, and teeth whitening. Management consulting: providing specialized advisory services for aesthetic medical practices. Furthermore, Raily trades in medical equipment and sells surgical implants alongside aesthetic medical skincare products. The company manages and operates a network of four private, for-profit aesthetic medical clinics located in China's Zhejiang and Anhui Provinces. It serves a diverse clientele, including individual retail customers and other aesthetic medical institutions. Founded in 2008 and headquartered in Hangzhou, People's Republic of China, Raily Aesthetic Medicine International Holdings Limited operates as a subsidiary of Ruide Consultation Limited.
أحدث البيانات المتاحة
0.106 HK$
−0.004 HK$ · -3.64%
تستخدم الأوقات اليومية المنطقة الزمنية HKT. قد تتأخر بيانات السوق.
Raily Aesthetic Medicine International Holdings Limited is an investment holding company primarily engaged in providing a comprehensive range of cosmetic medical services. Its operations are structured into three principal segments: Aesthetic Medical Services, Consulting Services, and the distribution of Aesthetic Medical Equipment Products. The company's service offerings include various aesthetic procedures such as: Surgical interventions: encompassing cosmetic surgeries performed on different areas of the face or body. Minimally invasive treatments: largely consisting of aesthetic injection procedures. Aesthetic dermatology: featuring diverse energy-based treatments. Aesthetic dental care: including orthodontic services, dental implants, and teeth whitening. Management consulting: providing specialized advisory services for aesthetic medical practices. Furthermore, Raily trades in medical equipment and sells surgical implants alongside aesthetic medical skincare products. The company manages and operates a network of four private, for-profit aesthetic medical clinics located in China's Zhejiang and Anhui Provinces. It serves a diverse clientele, including individual retail customers and other aesthetic medical institutions. Founded in 2008 and headquartered in Hangzhou, People's Republic of China, Raily Aesthetic Medicine International Holdings Limited operates as a subsidiary of Ruide Consultation Limited.
نطاق 52 أسبوعًا
السعر الحالي 0.106 HK$
تستخدم الأوقات اليومية المنطقة الزمنية HKT. قد تتأخر بيانات السوق.
Raily Aesthetic Medicine International Holdings Limited is an investment holding company primarily engaged in providing a comprehensive range of cosmetic medical services. Its operations are structured into three principal segments: Aesthetic Medical Services, Consulting Services, and the distribution of Aesthetic Medical Equipment Products. The company's service offerings include various aesthetic procedures such as: Surgical interventions: encompassing cosmetic surgeries performed on different areas of the face or body. Minimally invasive treatments: largely consisting of aesthetic injection procedures. Aesthetic dermatology: featuring diverse energy-based treatments. Aesthetic dental care: including orthodontic services, dental implants, and teeth whitening. Management consulting: providing specialized advisory services for aesthetic medical practices. Furthermore, Raily trades in medical equipment and sells surgical implants alongside aesthetic medical skincare products. The company manages and operates a network of four private, for-profit aesthetic medical clinics located in China's Zhejiang and Anhui Provinces. It serves a diverse clientele, including individual retail customers and other aesthetic medical institutions. Founded in 2008 and headquartered in Hangzhou, People's Republic of China, Raily Aesthetic Medicine International Holdings Limited operates as a subsidiary of Ruide Consultation Limited.
نطاق 52 أسبوعًا
السعر الحالي 0.106 HK$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (CNY) | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 | السنة المالية 2021 |
|---|---|---|---|---|---|
| الإيرادات | 184.51 مليون CNY | 199.34 مليون CNY | 189.38 مليون CNY | 164.52 مليون CNY | 188.37 مليون CNY |
| تكلفة البضاعة المباعة | 108.81 مليون CNY | 127.94 مليون CNY | 117.89 مليون CNY | 97.74 مليون CNY | 118.68 مليون CNY |
| الربح الإجمالي | 75.7 مليون CNY | 71.41 مليون CNY | 71.49 مليون CNY | 66.78 مليون CNY | 69.69 مليون CNY |
| البحث والتطوير | 2.02 مليون CNY | 717 ألف CNY | 1.6 مليون CNY | 2 مليون CNY | — |
| مصاريف البيع والمصاريف العمومية والإدارية | 67.55 مليون CNY | 89.47 مليون CNY | 92.39 مليون CNY | 85.17 مليون CNY | 89.26 مليون CNY |
| نفقات التشغيل | 70.65 مليون CNY | 90.08 مليون CNY | 93.97 مليون CNY | 86.95 مليون CNY | 88.98 مليون CNY |
| دخل الفوائد | 580.57 ألف CNY | 348 ألف CNY | 791 ألف CNY | 590 ألف CNY | 988 ألف CNY |
| مصاريف الفوائد | 2.68 مليون CNY | 2.81 مليون CNY | 2.8 مليون CNY | 2.8 مليون CNY | 2.42 مليون CNY |
| الاستهلاك والإطفاء | 21.93 مليون CNY | 28.16 مليون CNY | 26.18 مليون CNY | 23.19 مليون CNY | 14.53 مليون CNY |
| الدخل التشغيلي | 5.05 مليون CNY | −18.67 مليون CNY | −22.48 مليون CNY | −20.39 مليون CNY | −19.57 مليون CNY |
| صافي الدخل | 1.82 مليون CNY | −59.21 مليون CNY | −32.46 مليون CNY | −15.91 مليون CNY | −17.69 مليون CNY |
تم تحديث حقائق الشركة 17 أكتوبر 2026.
أحدث النتائج المعلنة
أحدث النتائج المعلنة
| الإجراء | تاريخ النفاذ | تفاصيل | تاريخ التسجيل | تاريخ الدفع |
|---|---|---|---|---|
تقسيم الأسهم | 19 مارس 2024 | 1:5 | — | — |
ساري 19 مارس 2024
1:5
2359.HK
WuXi AppTec Co., Ltd.
196.2 HK$
-2.19%
1276.HK
Jiangsu Hengrui Pharmaceuticals Co.,Ltd
47.60 HK$
-0.83%
6160.HK
BeOne Medicines AG
225 HK$
+4.36%
2269.HK
WuXi Biologics (Cayman) Inc.
48.20 HK$
-0.90%
3692.HK
Hansoh Pharmaceutical Group Company Limited
31.74 HK$
+1.15%
1801.HK
Innovent Biologics, Inc.
89.05 HK$
+1.48%
المحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.